Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Governments Are Not Following Advice on MERS

Tom Miles  |  September 3, 2015

GENEVA (Reuters)—Governments are not doing all they should to tackle the deadly Middle East Respiratory Syndrome, a committee of health experts at the World Health Organization said on Thursday.

The WHO’s emergency committee, which meets regularly to consider the international response to the disease, said in a statement that its advice had not been completely followed and some countries were not doing their duty to report all cases to the WHO.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Asymptomatic cases that have tested positive for the virus are not always being reported as required,” the committee said. Scientific research and virological surveillance were not always shared in a timely manner, it said.

“Inadequate progress has been made, for example, in understanding how the virus is transmitted from animals to people, and between people, in a variety of settings. The Committee was disappointed at the lack of information from the animal sector.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The committee said it wanted to alert public health authorities and animal and agricultural agencies to the “significant public health risks” posed by MERS and urged them to collaborate with each other and internationally.

MERS is caused by a coronavirus from the same family as the one that triggered China’s deadly 2003 outbreak of Severe Acute Respiratory Syndrome (SARS).

The WHO has been notified of 1,493 laboratory-confirmed cases, including at least 527 deaths, since September 2012. The vast majority of infections and deaths have been in Saudi Arabia, where more than 1,000 people have been infected.

But many other countries have been affected, including South Korea, where a two-month outbreak earlier this year infected 186 people, killed 36 and put nearly 17,000 in quarantine.

MERS is being spread by transmission from camels in Middle Eastern countries and by human-to-human transmission in hospitals when travelers take the disease abroad and then fall ill, as in the South Korean case.

The WHO’s emergency committee said the virus was still spreading because there was too little awareness about the dangers, too little engagement in tackling the disease, and too little effort to prevent its spread in hospitals.

Although great efforts had been made, without more progress, “individual countries and the global community will remain at significant risk for further outbreaks”, the committee said.

It added that the current outbreak was occurring close to the Muslim Hajj pilgrimage and many pilgrims would return to countries with weak surveillance and health systems, threatening a repeat of South Korea’s experience of a sudden flare-up of cases.

Page: 1 2 | Single Page
Share: 

Filed under:FacilityPractice Support Tagged with:ChinahospitalMiddle East Respiratory Syndrome (MERS)World Health Organization

Related Articles

    Chikungunya: What Every Rheumatologist Needs to Know

    November 2, 2014

    How to spot, diagnose and treat this rapidly spreading mosquito-borne viral illness whose symptoms mimic arthritis

    Preparing Immunocompromised Patients for Risks of Traveling Abroad

    September 15, 2015

    Summer is a season for travel, so if your immunocompromised patients plan to journey to regions where there are outbreaks of infections, such as chikungunya, tuberculosis, typhoid, yellow fever or other diseases, communication and preparation may prevent serious health events. “The world teems with disease-causing organisms, and almost every infection is more serious in the…

    Why Rheumatologists Should Care about Zika: How It’s Transmitted & Spreading in the U.S.

    September 26, 2016

    Rheumatologists are already familiar with one mosquito-borne virus, chikungunya, whose presentation mimics arthritis. Now, with its recent spread to Puerto Rico and the Southeastern U.S., Zika, another mosquito-borne virus, has become an international public health concern. Sexual transmission of the virus was recently confirmed, expanding the virus’s threat…

    Don’t Forget the Host: COVID-19 Cytokine Storm

    March 16, 2020

    The new coronavirus outbreak, COVID-19, reminds us how we have struggled to keep ahead of mutating pathogens through the ages.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences